BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12906759)

  • 1. Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin.
    Nozawa T; Tamai I; Sai Y; Nezu J; Tsuji A
    J Pharm Pharmacol; 2003 Jul; 55(7):1013-20. PubMed ID: 12906759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
    Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
    Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.
    Kullak-Ublick GA; Ismair MG; Stieger B; Landmann L; Huber R; Pizzagalli F; Fattinger K; Meier PJ; Hagenbuch B
    Gastroenterology; 2001 Feb; 120(2):525-33. PubMed ID: 11159893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.
    Mahagita C; Grassl SM; Piyachaturawat P; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G271-8. PubMed ID: 17412826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.
    Ishiguro N; Maeda K; Kishimoto W; Saito A; Harada A; Ebner T; Roth W; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1109-15. PubMed ID: 16611857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
    Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes?
    Briz O; Romero MR; Martinez-Becerra P; Macias RI; Perez MJ; Jimenez F; San Martin FG; Marin JJ
    J Biol Chem; 2006 Oct; 281(41):30326-35. PubMed ID: 16877380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.
    Nozawa T; Minami H; Sugiura S; Tsuji A; Tamai I
    Drug Metab Dispos; 2005 Mar; 33(3):434-9. PubMed ID: 15608127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation.
    Tirona RG; Leake BF; Wolkoff AW; Kim RB
    J Pharmacol Exp Ther; 2003 Jan; 304(1):223-8. PubMed ID: 12490595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
    Takeuchi K; Sugiura T; Umeda S; Matsubara K; Horikawa M; Nakamichi N; Silver DL; Ishiwata N; Kato Y
    Drug Metab Dispos; 2011 Jun; 39(6):1088-96. PubMed ID: 21422191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.
    Gao B; Hagenbuch B; Kullak-Ublick GA; Benke D; Aguzzi A; Meier PJ
    J Pharmacol Exp Ther; 2000 Jul; 294(1):73-9. PubMed ID: 10871297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
    Hirano M; Maeda K; Shitara Y; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Oct; 311(1):139-46. PubMed ID: 15159445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity.
    Nozawa T; Sugiura S; Nakajima M; Goto A; Yokoi T; Nezu J; Tsuji A; Tamai I
    Drug Metab Dispos; 2004 Mar; 32(3):291-4. PubMed ID: 14977862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration.
    Liederer BM; Phan KT; Ouyang H; Borchardt RT
    J Pharm Sci; 2005 Dec; 94(12):2676-87. PubMed ID: 16258984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The organic anion transport polypeptide 1d1 (Oatp1d1) mediates hepatocellular uptake of phalloidin and microcystin into skate liver.
    Meier-Abt F; Hammann-Hänni A; Stieger B; Ballatori N; Boyer JL
    Toxicol Appl Pharmacol; 2007 Feb; 218(3):274-9. PubMed ID: 17198718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-mediated hepatic uptake of a novel nonrenal excretion type uric acid generation inhibitor, Y-700.
    Sai Y; Kato Y; Nakamura K; Kato S; Nishimura T; Kubo Y; Tamai I; Yang S; Hu Z; Yamada I; Tsuji A
    J Pharm Sci; 2006 Feb; 95(2):336-47. PubMed ID: 16369928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics.
    Nakakariya M; Shimada T; Irokawa M; Koibuchi H; Iwanaga T; Yabuuchi H; Maeda T; Tamai I
    Pharm Res; 2008 Mar; 25(3):578-85. PubMed ID: 17891554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
    Yang JZ; Chen W; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.